Opus Genetics CEO George Magrath, MD, discusses how the company introduced virtual reality-enabled assessments and relied on digital endpoints to better measure participants’ vision changes.
- Why HEOR Keeps Arriving Too Late — And How ClinOps Can Fix It
- Accelerating Clinical Innovation With Open-Source Medical Platforms
- From Supercomputers To The Cloud: How Pharma's R&D Infrastructure Transformation Impacts Clinical Trials
- How To Identify Patient-Centric Risks In The TMF With AI And Automation
- How The TMF Demonstrates Patient Safety And Rights In DCTs
- Begin Your AI-Led Digital Clinical Transformation With A Phased Approach
- How AI Is Rewriting The Future Of TMF And Clinical Quality
- Penetration Testing In Healthcare: Common Vulnerabilities And Programs To Address Them
ON-DEMAND WEBINARS
Here, viewers will learn about best practices for developing an effective data collection strategy and selecting technology solutions that align with research needs.
The benefits of integrating EHR data with an EDC range from reducing duplicate documentation and errors to enriching the clinical dataset with real-world data. Why aren’t more people doing it?
TransPerfect Life Sciences' C3 Summit brings to you virtual sessions on how the paper to digital migration is evolving, the use and application of eCOA migration technology, and setting up successful eCOA solutions.
During this fireside chat, data experts from ActiGraph, VivoSense, and Elektra Labs share cautionary tales of data collection gone awry and how the teams found creative solutions for the problems at hand. Panelists recount real life examples of data collection efforts that missed the mark and provide strategies, tools, and guidance to help clinical teams avoid common missteps in the first place.
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
![Patient with ipad]( "How eConsent Delivers Value For Sponsors")
How eConsent Delivers Value For SponsorsDelve into the data substantiating experiences with electronic informed consent to better understand their positive impact on the outcomes of clinical trials.
-
![Nurse patient checking medical exams-GettyImages-1487540665]( "How Pfizer Used Wearable DHTs To Reveal Meaningful Treatment Effects In Cancer Cachexia")
How Pfizer Used Wearable DHTs To Reveal Meaningful Treatment Effects In Cancer CachexiaWearable digital health technologies (DHTs) played a crucial role in assessing patient-centric outcomes during pfizer's study into the benefits of using ponsegromab for treating cancer cachexia.
-
![science drug development data iStock-1209661917]( "How Can Electronic Data Capture Better Serve Decentralized Clinical Trials?")
How Can Electronic Data Capture Better Serve Decentralized Clinical Trials?Newer, nimbler technology providers face a steep climb if they want to convince sponsors to sunset traditional EDC in favor of direct data capture only, or a unified decentralized trial platform that everything plugs into. Will EDC evolve to fix its existing problems, or will a different type of decentralized trial platform (or single platform model) replace pick-and-pull, add-and-subtract modules of clinical trial technology?
-
![GettyImages-866433760 data]( "Achieving Self Sufficiency In Data Collection For Optinose")
Achieving Self Sufficiency In Data Collection For OptinoseUncover how this specialty pharmaceutical company was able to gain control over its EDC environment by adopting a solution their team could use in-house.
-
![electronic-medical-technology-GettyImages-1204743045]( "Broadening Eligibility Criteria Among Cancer Clinical Trials Patients")
Broadening Eligibility Criteria Among Cancer Clinical Trials PatientsThis study challenges the commonly applied exclusionary approach to clinical trials, particularly cancer trials, that underrepresent certain populations and limit the generalizability of research advancements.
-
![Person using digital tablet-GettyImages-1421626437]( "The Transformative Role Of Digital Health Technologies")
The Transformative Role Of Digital Health TechnologiesDigital health technologies are transforming clinical trials through decentralization, improved data, and patient-centric approaches, driving efficiency and accessibility.
-
![GettyImages-1386486759 EDC]( "Evaluating EDC Systems In A Modern DM Landscape")
Evaluating EDC Systems In A Modern DM LandscapeThis guide provides five crucial recommendations to refine evaluation strategies and choose the right solution for today's complex clinical data environment, optimizing data collection practices.
-
![GettyImages-1408596915 eTMF]( "Achieving Faster, Simpler Validation Through Crowdsource UAT")
Achieving Faster, Simpler Validation Through Crowdsource UATAn approach most often seen in the larger tech space, crowdsource UAT can offer several potential advantages for the clinical trial industry and eTMF validation.
-
![3-cancer_1044148970]( "Why Oncology Drug Development Lags In Digital Biomarkers")
Why Oncology Drug Development Lags In Digital BiomarkersDespite technological advances, oncology drug development research has lagged in adopting wearable digital biomarkers. Explore this space's unique challenges and the benefits of wearable technology.
-
![GettyImages-653836738 data researcher]( "Shaping The Future Of eCOA User Acceptance Testing")
Shaping The Future Of eCOA User Acceptance TestingProactive planning by sponsors and early User Acceptance Testing (UAT) involvement in the eCOA design process can substantially improve study quality, efficiency, and consistency.
